AI MARKET SCANNING

Rocket Pharmaceuticals Inc

📅 Next Catalyst: Nov 05, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +1.15%
MAX GAP RECORD +4.46%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $RCKT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE)
+0.55%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
+2.72%
Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE)
+1.32%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
+0.93%
Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN)
+0.00%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+1.64%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
+1.60%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.5%
Bullish Gaps (7)
Bearish Gaps (1)
Neutral / Flat (6)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $RCKT

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-05 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1359m +7.85%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗